Regionally selective increases in m opioid receptor density in the brains of suicide victims

Ruth Gross-Isseroff1, Kathryn A. Dillon2, Malka Israeli1 and Anat Biegon1,2

  1. Department of Neurobiology, Weizmann Institute of Science, 76100 Rehovot (Israel) and 2 Department of Psychiatry, NYU Medical Center, New York, NY 10016 (U.S.A.)

(Accepted 17 July 1990)

Key words: [3H]Tyr-d-Ala-Gly-ol; Autoradiography; Human brain; Suicide; m -Receptor; Opioid receptor

The effect of aging and suicide on m opioid receptors was studied in the human brain postmortem. Quantitative autoradiography with [3H]DAGO revealed region specific increases in m receptor density with age. Suicide was accompanied by a significant increase, up to 9-fold, in m receptor density in the young, but not the old, subjects as compared to age-matched controls. This effect was evident in the frontal and temporal cortical gyri. Saturation binding studies with the same ligand show that the increased binding in the elderly and in the young suicides is due to an increase in receptor density (Bmax) rather than affinity (Kd).

The endogenous opioid system is involved in the control of numerous brain mechanisms, including pain perception1,16,20 and central reward systems7,28. There is also a growing body of behavioural2,10,11,18,29 and pharmacological3,5,8,15,24,27 evidence linking the opioid system to the pathophysiology of depression and the mode of action of antidepressant drugs. Thus, anhedonia (a defect in the central reward systems) and alterations in pain perception are common features of depression2,10,11,18,29 and studies in experimental animals show that antidepressant drugs are capable of modifying the binding parameters of opioid receptors3,5,8,15,24,27. While neurochemical studies of the brains of suicide victims are often used in attempts to elucidate the biological basis of affective disorders4,9,12,13,17,26, opioid receptors have not been examined in this context to date. Since the biochemical changes associated with central disorders are often regioally selective (see for example refs. 9, 12, 13), we have used the quantitative autoradiographic approach to examine possible regional differences in m opioid receptors between the brains of suicide victims and age- and sex-matched controls.

Brains were obtained at autopsy from the New Yord City medical examiner’s office and from the Institute of Forensic Medicine at Jaffa. Exclusion criteria were the presence of neuropathological changes, a history or direct evidence of drug abuse, alcoholism or mental disorders other than depression and the presence of drugs in the brain as determined by wide spectrum toxicology performed by the medical examiners’ toxicological laboratories. The present study is based on 14 pairs of brains, matched for age (controls: 41.3 + 22.1 years, suicides: 41.4 + 20.4, mean + S.D.), postmortem delay (controls: 24.5 + 11.8 h, suicides: 22.4 + 10.4, mean + S.D.) and sex (9 men and 5 women in each group). The most common causes of death in both groups were multiple trauma and asphyxiation,, as previously described13.

Brains were removed from the cranium, cut into approx. 2.5 cm-thick blocks which were immediately frozen over dry ice, and kept at - 70°C. Coronal sections, 40 m m thick, cut on a Bright whole body cryotome at -15°C, were thaw-mounted onto gelatin-coated glass slides and kept overnight at -20°C. Slides were incubated for 60 min, at 25°C, with 1 nM [3H]DAGO (N.E.N., 58 Ci/mmol) in 50 mM Tris-HCl buffer, pH 7.423. Non-specific binding was determined in the presence of 1 m M etorphine. A 9-min wash in the same ice-cold buffer followed the incubation. Slides were then dipped in ice-cold water to remove buffer salts, dried on a 50°C hot plate and apposed to tritium-sensitive film (Amersham [3H]Hyperfilm) for 12 weeks. The film was coexposed to commercial (Amersham) tritiated standards. It was then manually developed and fixed with Kodak developer and fixer. Sections were stained with Cresyl violet for anatomical reverence and several neuroanatomical texts were used for identification of structures6,22. All sections were obtained from the right cerebral hemisphere, at the level of the amygdala or hippocampus and at the level of prefrontal cortex. Since preliminary results showed that under these conditions non-specific binding was at the level of film background, two consecutive sections from each brain and each anatomical level were run to obtain total binding, which in this case equalled specific binding. Experiments were run in a matched pair design so that each one included sections from a suicide brain and its matched control. Autradiograms were analyzed with the aid of an IBM-PC based computerized image analysis system with a PC-vision digitizing board (Imaging Technology Inc.) and customized software. Standardization curves derived from the tritiated standards were used to convert gray level readings of the autoradiograms into equivalents of fmol [3H]DAGO/mg protein. All measurements were done in dupicate for each brain and each region.

As expected, we found a highly heterogeneous distribution of m receptors in the human brain. Thus, high density of binding appeared over the frontal cortex and caudate, while parietal and especially occipital cortex and hippocampus were characterized by low density in binding (Fig. 1). (***A note from typist: in the photocopy of this article that I am working from the picture in fig 1 is so bad that I haven’t bothered to scan it in. You just can’t see anything. The caption from fig 1 is: "Distribution of m receptors in suicide and control brains. Figure presents autoradiograms of [3H]DAGO binding in coronal sections at the level of the hippocampus taken from a control brain, age 40 years (top left) and a suicide brain, age 38 years (top right). Bottom presents a Cresyl violet stained section adjacent to the one that created the autoradiogram at the right top. hp, hippocampus; c, tail of caudate nucleus; I, insular cortex; t, thalamus."***)Initial analysis has shown highly significant positive correlation between age and m binding in most brain regions (Table I). In addition, some biochemical correlates of suicide appear to be age-specific13. We therefore divided the sample into young and aged subgroups at the median age of 41 years, and performed two-way analyses of variance (group* age) corrected for unbalanced designs. Significant group effects were found in the medial frontal gyrus, superior temporal gyrus and medial temporal gyrus (Table I). Several trends were also present (Table I). Individual comparisons of the young suicides to their age-matched controls revealed significant increases in m receptor binding in the precentral, postcentral, superior temporal and cingulate cortical tyri of the suicides. A similar trend (0.05 < P < 0.10) was apparent also in the frontal superior, medial temporal, lateral occipitotemporal and parahippocampal gyri. In the aged subgroup, where age alone was correlated with increased binding, there was no further increase in the suicides in most regions, with the exception of the medial frontal gyrus (Table I). Much smaller differences were found in the prefrontal cortex (Table I).

TABLE I

Distribution of m receptors in young and old suicides and controls

Mean + S.E.M. [3H]DAGO bound

 

Region

Young

Old

Control (n)

Suicide (n)

Ratio

Control (n)

Suicide (n)

Ratio

r (P)

ANOVA

Cortex

Prefrontal level

Superior frontal gyrus

162 + 33 (6)

189 + 42 (5)

1.2

257 + 85 (6)

298 + 60 (4)

1.2

0.46 (0.03)

#

Medial frontal gyrus

118 + 27 (6)

154 + 19 (5)

1.3

208 + 73 (6)

241 + 56 (4)

1.2

0.41 (0.06)

#

Inferior frontal gyrus

142 + 32 (6)

192 + 19 (5)

1.4

221 + 76 (6)

394 + 40 (4)

1.8

0.41 (0.06)

* *, # #

Orbital gyri

160 + 33 (6)

203 + 28 (5)

1.3

241 + 83 (6)

374 + 64 (4)

1.6

0.38 (0.10)

#

Gyrus rectus

185 + 44 (6)

247 + 35 (5)

1.3

253 + 82 (6)

328 + 44 (4)

1.3

Cingulate gyrus

206 + 29 (6)

218 + 40 (5)

1.1

258 + 94 (6)

369 + 56 (4)

1.4

*

Frontoparietal level*

Cingulate gyrus

78 + 25 (6)

254 + 69 (4)

3.3

157 + 81 (5)

207 + 47 (6)

1.3

*

Superior frontal gyrus

22 + 8 (6)

114 + 57 (4)

5.2

44 + 42 (5)

60 + 31 (6)

1.4

Precentral gyrus

16 + 10 (6)

133 + 46 (5)

8.4

62 + 55 (5)

47 + 26 (6)

0.8

Postcentral gyrus

26 + 8 (6)

233 + 70 (5)

9.0

90 + 50 (6)

145 + 42 (5)

1.6

* * *

Insula

29 + 12 (5)

96 + 66 (2)

3.3

133 + 51 (5)

217 + 85 (5)

1.6

0.62 (0.008)

Superior temporal gyrus

22 + 10 (6)

100 + 17 (4)

4.5

172 + 65 (5)

188 + 69 (5)

1.1

0.72 (0.0004)

# #

Medial temporal gyrus

66 + 21 (7)

145 + 33 (4)

2.2

196 + 68 (5)

294 + 61 (5)

1.5

0.75 (0.0001)

* *, # # #

Inferior temporal gyrus

97 + 32 (7)

158 + 61 (3)

1.6

189 + 59 (5)

257 + 58 (5)

1.4

0.70 (0.0004)

#

Lateral occipitotemporal gyrus

82 + 25 (7)

202 + 38 (2)

2.5

168 + 50 (5)

233 + 47 (5)

1.4

0.67 (0.002)

* *

Parahippocampal gyrus

26 + 18 (7)

155 + 117 (2)

6.0

71 + 22 (4)

85 + 48 (5)

1.2

Thalamus

Medial nucleus

314 + 51 (6)

388 + 118 (3)

1.2

242 + 62 (4)

463 + 45 (5)

1.9

* *

White matter

0 + 0 (6)

0 + 0 (5)

0 + 0 (6)

0 + 0 (7)

Results represent means + S.E.M. of specific [3H]DAGO binding in n brains, expressed as fmol/mg protein.

r, Pearson coefficient of correlation between specific binding and age.

P, probability of r.

+0.05 < P < 0.10 in a two-tailed t-test comparing suicides and controls.

++P < 0.05 in a two-tailed t-test comparing suicides and controls.

ANOVA, results of a two-way (group*age) analysis of variance corrected for unbalanced designs, where :* = borderline group effect, 0.05 < P < 0.10; * * = significant group effect, P < 0.05; * * * = significant group effect, P < 0.01; # = borderline age effect, 0.05 < P < 0.10; # #= significant age effect, P < 0.05; # # # = significant age effect, P < 0.01.

Ratio, suicide/control values.

TABLE II

Saturation parameters of m opioid receptors in the human brain postmortem: effects of age and suicide

Young

Old

Control

Suicide

Control

Suicide

(n = 7)

(n = 5)

(n = 6)

(b = 6)

Kd (nM)

0.8 + 0.19

0.53 + 0.19

0.53 + 0.23

0.56 + 0.17

Bmax (fm/mg P)#

24.0 + 13.8

44.1 + 2.7*

54.1 + 22.2*

51.0 + 20.5

Age (years)

21.6 + 6.3

27.8 + 7.6

61.3 + 11.7

58.0 + 12.8

PMD (hours)

20.1 + 22.8

22.8 + 15.6

27.3 + 15.2

19.3 + 4.4

Table presents meant + S.D. of n subjects/group.

#, P < 0.05, group effect in a two-way ANOVA for unbalanced designs.

*, P< 0.01. t10 = 3.26, Student’s t-test, two-tailed, compared to young controls.

+, P < 0.05, t10 = 2.82, Student’s t-test, two-tailed, compared to young controls.

To determine whether the differences in binding were due to a change of affinity (Kd) or density (Bmax) of receptors, we have conducted saturation binding assays on 600mg homogenized samples of the superior frontal gyrus from the same brains. Samples were homogenized in 10 vols. of 50 mM Tris-HCl buffer, pH 7.4, using the Ultra-Turrax, setting 6, for 20 s. Homogenates were centrifuged at 20000 g for 15 min at 4°C. The resulting pellets were resuspended and the procedure repeated. To assess binding, [3H]DAGO (N.E.N., 40.8 Ci/mmol) was used. The tissue was suspended in 50 vols. of 50mM Tris- HCl buffer, pH 7.4, and 8 concentrations of titrated ligand (0.2-6.0 nM) were added to triplicate samples of the homogenate. A total volume of 1 ml was incubated for 45 min at 25°C. Non-specific binding was determined in the presence of 2 m M naloxone. Separation of bound from free drug was accomplished by filtration through GF/B type filters followed by 2 x 5 ml washes with ice cold buffer. Radioactivity of the dried filters was determined by scintillation counting. Kd and Bmax values were computed from Scatchard 25 plots using the Ligand PC program. These analyses show that both age and suicide effects are due to a change in Bmax rather than Kd (Table II).

The mechanism underlying the observation of higher m receptor density in young suicides and the elderly is not known. It could reflect deregulation of receptor synthesis, but a more likely explanation would be an adaptive response of the postsynaptic receptors to altered levels of presynaptically released endogenous peptides. There is indeed some evidence for alterations in b -endorphin secretion in depressed patients19, and chronic electroconvulsive shock (ECS) was followed by an increase in plasma b -endorphin21. In experimental animals, ECS and tricyclic antidepressant drugs have been shown to increase brain levels of some opioid peptides while decreasing m receptor binding14. These findings, together with our observation of increased

m receptors in the brains of suicide victims, strongly suggest that central opioid systems do indeed contribute to the pathophysiology of depression and suicide. Additional opioid marders need to be studied to better our understanding of this contribution and possibly indicate novel approaches to therapeutic intervention.

This study was supported by grants from the Israel Ministry of Health Chief Scientist’s Office and NIDA Grant No. DA06584-01.

    1. Akil, H., Mayer, D.J. and Liebeskind, J.C., Antagonism of stimulation produced analgesia by naloxone, a norcotic antagonist, Science, 191 (1976) 961-962
    2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-III), APA, New York, 1980
    3. Antkiewicz-Michaluk, L., Rokosz-Pelc, A. and Vetulani, J., Eur. J. Pharmacol., 102 (1984) 179-181.
    4. Arora, R.C. and Meltzer, H.Y., Serotonin (5-HT2) recognition sites of [3H]-imipramine binding (IB) sites in the brains of suicide victims, Soc. Neurosci. Abstr., 13 (1987( 1473.
    5. Baraldi, M., Poggioli, R., Santi, M., Vergoni, A.V. and Bertononi, A., Antidepressants and opiates interaction: pharmacological and biochemical evidences, Pharmacol. Res. Commun., 15 (1983) 843-957.
    6. Barr, M.L., The Human Nervous System. An Anatomical Viewpoint, Harper and Row, New York, 1974.
    7. Belluzzi, J.D. and Stein, L., Enkephalin may mediate euphoria and drive reduction reward, Nature, 266 (1977) 556-558.
    8. Biegon, A. and Samuel, D., Interaction of tricyclic antidepressants with opiate receptors. Biochem. Pharmacol., 29 (1980) 460-462
    9. Biegon, A. and Israeli, M., Regionally selective increases in b -adrenergic receptor density in the brains of suicide victims, Brain Research, 442 (1988) 199-203
    10. Blumer,D. and Heilbronn, M., Chronic pain as a variant of depressive disease, J. Nerv. Ment. Dis., 170 (1982) 381-394.
    11. Davis, G.C., Buchsbaum, M.S. and Bunney, W.E., Analgesia to painful stimuli in affective illness, Am. J. Psychiatry, 136 (1979) 1148-1151.
    12. Gross-Isseroff, R., Salama, D., Israeli, M. and Biegon, A., Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effects of suicide, Brain Research, 507 (1990) 208-215.
    13. Hamon, M., Gozlan, H., Bourgoin, S., Benoliel, J.J., Mauborgne, A., Taquet, H., Cesselin, F. and Mico, J.A., Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine and amitriptyline, Neuropharmacology, 26 (1987) 531-539.
All material on this site is subject to the laws of copyright. Please do not copy or disseminate any of my work in any way without asking me first directly by email and gaining my express written consent. (c) 1997 egad-dict@geocities.com If you quote material from this page you can use this for citation:[Rose Whithers(URL of the page you are quoting from)] No responsibility is taken for the accuracy or any other problem anyone may have with this page, I try my best but I'm not infallible. If you have any doubts check it out for yourself.




This page hosted by GeoCities Get your own Free Home Page
1